Publications by authors named "Suneet Agarwal"

43 Publications

Telomerase RNA processing: Implications for human health and disease.

Stem Cells 2020 Sep 1. Epub 2020 Sep 1.

Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
September 2020

Impaired reproductive function and fertility preservation in a woman with a dyskeratosis congenita.

J Assist Reprod Genet 2020 May 13;37(5):1221-1225. Epub 2020 May 13.

Department of Obstetrics and Gynecology, New York University Langone Health, 550 First Avenue, NBV-9N1A, New York, NY, 10016, USA.

View Article and Find Full Text PDF
May 2020

Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Cell Stem Cell 2020 06 21;26(6):896-909.e8. Epub 2020 Apr 21.

Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Stem Cell Institute, Boston, MA, USA; Department of Pediatrics, Harvard Medical School, Boston, MA, USA; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA; Manton Center for Orphan Disease Research, Boston Children's Hospital, Boston, MA, USA; Harvard Initiative in RNA Medicine, Boston, MA, USA. Electronic address:

View Article and Find Full Text PDF
June 2020

Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.

Authors:
Suneet Agarwal

Hematol Oncol Clin North Am 2018 Aug 28;32(4):669-685. Epub 2018 May 28.

Division of Hematology/Oncology, Harvard Medical School, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, 1 Blackfan Circle, Karp 07214, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

Exudative Vitreoretinopathy in Dyskeratosis Congenita.

Ophthalmology 2017 08;124(8):1246

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Retina Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF
August 2017

Retinal findings and a novel TINF2 mutation in Revesz syndrome: Clinical and molecular correlations with pediatric retinal vasculopathies.

Ophthalmic Genet 2017 Jan-Feb;38(1):51-60. Epub 2017 Jan 17.

a Retina Service, Department of Ophthalmology , Massachusetts Eye and Ear, Harvard Medical School , Boston , Massachusetts , USA.

View Article and Find Full Text PDF
November 2017

A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding.

Blood 2016 10 1;128(16):2089-2092. Epub 2016 Sep 1.

Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, MA.

View Article and Find Full Text PDF
October 2016

Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.

Nat Genet 2015 Dec 19;47(12):1482-8. Epub 2015 Oct 19.

Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
December 2015

Simultaneous sequencing of oxidized methylcytosines produced by TET/JBP dioxygenases in Coprinopsis cinerea.

Proc Natl Acad Sci U S A 2014 Dec 18;111(48):E5149-58. Epub 2014 Nov 18.

Division of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037; Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093

View Article and Find Full Text PDF
December 2014

A young adult with aplastic anemia and gray hair.

Clin Chem 2013 Jan;59(1):47-50

Departments of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article and Find Full Text PDF
January 2013

The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine.

Nat Protoc 2012 Oct 27;7(10):1909-17. Epub 2012 Sep 27.

La Jolla Institute for Allergy and Immunology, La Jolla, California, USA.

View Article and Find Full Text PDF
October 2012

CTC1 Mutations in a patient with dyskeratosis congenita.

Pediatr Blood Cancer 2012 Aug 24;59(2):311-4. Epub 2012 Apr 24.

Division of Hematology/Oncology, Stem Cell Program, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
August 2012

Telomere dynamics in dyskeratosis congenita: the long and the short of iPS.

Cell Res 2011 Aug 26;21(8):1157-60. Epub 2011 Jul 26.

Division of Hematology/Oncology, Children's Hospital Boston, MA 02115, USA.

View Article and Find Full Text PDF
August 2011

Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells.

Nature 2011 May 8;473(7347):394-7. Epub 2011 May 8.

Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
May 2011

Cellular therapy for fanconi anemia: the past, present, and future.

Biol Blood Marrow Transplant 2011 Jan;17(1 Suppl):S109-14

The Division of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, University of Minnesota Blood and Marrow Transplant Program, Minneapolis, Minnesota, USA.

View Article and Find Full Text PDF
January 2011

Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells.

Nat Genet 2010 Dec 7;42(12):1113-7. Epub 2010 Nov 7.

Stem Cell Transplantation Program, Division of Pediatric Hematology and Oncology, Manton Center for Orphan Disease Research, Children's Hospital Boston and Dana Farber Cancer Institute, Boston, Massachusetts, USA.

View Article and Find Full Text PDF
December 2010

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2.

Nature 2010 Dec;468(7325):839-43

Department of Pathology, Harvard Medical School, Immune Disease Institute and Program in Cellular and Molecular Medicine, Children’s Hospital Boston, Boston, Massachusetts 02115, USA.

View Article and Find Full Text PDF
December 2010